BUPROPION Safety Questions, BUPROPION Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about BUPROPION. Our extensive database of BUPROPION adverse events and BUPROPION warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about BUPROPION

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



BUPROPION Safety Reports

Total BUPROPION reports: 405.
BUPROPION FDA safety alerts: 2004 2005 .
Reported deaths: 29    Reported hospitalizations: 41.
Take BUPROPION Side Effects Survey or Share Your BUPROPION Story. Read More Here.

Showing 1-75 of 405 Next >

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Feb 15, 2007. Male patient, 36 years of age, weighting 320.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: crying, depression, insomnia, mood swings, suicidal behaviour. BUPROPION dosage: 300 MG QD PO. During the same period patient was treated with ENALAPRIL MALEATE, LOVASTATIN, INDOMETHACIN, SEROQUEL, PREVACID, HYDROCHLOROTHIAZIDE. Patient died.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, 39 years of age, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: formication, hallucination, tactile. BUPROPION dosage: unknown. During the same period patient was treated with BUSPIRONE, FELODIPINE, FLUOXETINE, HYDROCHLOROTHIAZIDE, OMEPRAZOLE, SIMVASTATIN, SULINDAC, PSYLLIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Feb 27, 2007. Female patient, 40 years of age, was diagnosed with major depression, migraine, insomnia and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: formication, hallucination, tactile. BUPROPION dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, LORATADINE, MONTELUKAST, RANITIDINE, RIBOFLAVIN, FIORICET, GABAPENTIN, TRAZODONE. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Mar 07, 2007. Female patient, weighting 4.63 lb, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anorexia, poor weight gain neonatal. BUPROPION dosage: 200MG SEE TEXT. During the same period patient was treated with PRENATAL VITAMINS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on Mar 07, 2007. Female patient, 32 years of age, was diagnosed with major depression, bipolar disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. BUPROPION dosage: 300MG PER DAY. During the same period patient was treated with LAMOTRIGINE. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Female patient, weighting 135.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: nausea, nervousness, stomach discomfort. BUPROPION dosage: 300 MG 1 PO DAILY PO. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 08, 2007. Female patient, weighting 135.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, disease recurrence, dizziness, stomach discomfort. BUPROPION dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 38 years of age, weighting 200.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: akathisia, condition aggravated, depression. BUPROPION dosage: 300 MG 1 QD PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 13, 2007. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: crying, stress, tinnitus. BUPROPION dosage: 300 MG ONCE DAILY PO. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, 39 years of age, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: formication, hallucination, tactile. BUPROPION dosage: unknown. During the same period patient was treated with BUSPIRONE, FELODIPINE, FLUOXETINE, HYDROCHLOROTHIAZIDE, OMEPRAZOLE, SIMVASTATIN, SULINDAC, PSYLLIUM HUSK. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Feb 27, 2007. Female patient, 40 years of age, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: formication, hallucination, tactile. BUPROPION dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, LORATADINE, MONTELUKAST, RANITIDINE HYDROCHLORIDE, RIBOFLAVINE, FIORICET, GABAPENTIN, TRAZODONE. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Male patient, weighting 5.95 lb, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: trisomy 21. BUPROPION dosage: 300MG PER DAY. During the same period patient was treated with CELEXA. Patient recovered.

Physician from UNITED STATES reported BUPROPION problem on Mar 14, 2007. Female patient, weighting 138.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: condition aggravated, depression. BUPROPION dosage: 150MG PO BID. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 171.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, tremor, weight increased. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 20, 2007. Female patient, 45 years of age, weighting 220.0 lb, was diagnosed with bipolar disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, mood altered. BUPROPION dosage: 300 MG DAILY PO. During the same period patient was treated with WELLBUTRIN. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Female patient, 43 years of age, weighting 250.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, condition aggravated, depression, dizziness, feeling abnormal, irritable bowel syndrome, lethargy. BUPROPION dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Pharmacist from UNITED STATES reported BUPROPION problem on Mar 21, 2007. Female patient was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: affective disorder, disease recurrence. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Female patient, weighting 165.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: akathisia, anxiety, mood altered, mood swings. BUPROPION dosage: 300 MG QAM PO. During the same period patient was treated with LEXAPRO, KLONOPIN, DOXEPIN. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on Mar 22, 2007. Female patient was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: affect lability, agitation, anxiety, dizziness, impulsive behaviour, insomnia, nervousness, nightmare. BUPROPION dosage: 150 MG 1 Q AM PO. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 16, 2007. Female patient, 38 years of age, weighting 158.7 lb, was diagnosed with contraception, skin infection and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: overdose. BUPROPION dosage: 150MG TWICE PER DAY. During the same period patient was treated with FLUCLOXACILLIN, ACETAMINOPHEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 21, 2007. Female patient, 31 years of age, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: abortion induced. BUPROPION dosage: unknown. During the same period patient was treated with PRENATAL VITAMINS, ASPIRIN. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Male patient, weighting 150.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 26, 2007. Female patient, weighting 166.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: asthenia, nausea, sexual dysfunction. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on Mar 30, 2007. Female patient, 40 years of age, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: feeling jittery. BUPROPION dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BUPROPION problem on Mar 30, 2007. Female patient, 49 years of age, weighting 140.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depressed mood, depression, feeling abnormal, tearfulness. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Male patient, weighting 8.16 lb, was diagnosed with bipolar disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: adverse event, hospitalisation. BUPROPION dosage: unknown. During the same period patient was treated with LAMOTRIGINE, XANAX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on Mar 30, 2007. Female patient was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. BUPROPION dosage: 300MG PER DAY. During the same period patient was treated with KLONOPIN, PROGESTERONE, PRENATAL VITAMINS, ASPIRIN. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Female patient, 28 years of age, weighting 145.0 lb, was diagnosed with anxiety, somnolence and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal, headache, hyperacusis, irritability, memory impairment, vision blurred. BUPROPION dosage: 150MG 1 PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 05, 2007. Female patient, 36 years of age, weighting 180.0 lb, was diagnosed with attention deficit/hyperactivity disorder, seasonal affective disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, condition aggravated, depression, dizziness, headache, nausea, nicotine dependence. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2007. Female patient, 26 years of age, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: tachycardia. BUPROPION dosage: unknown. During the same period patient was treated with AMISULPRIDE, MIRTAZAPINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 09, 2007. Male patient, 57 years of age, weighting 400.0 lb, was diagnosed with bipolar i disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, feeling abnormal, somnolence. BUPROPION dosage: 300MG 1 DAILY PO. During the same period patient was treated with LAMICTAL, GLYBURIDE, METFORMIN, METOPROLOL SUCCINATE, LISINOPRIL, HYDROCHLOROTHIAZIDE, FUROSEMIDE. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, 43 years of age, weighting 163.0 lb, was diagnosed with anxiety, depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure increased, depression. BUPROPION dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BUPROPION problem on Apr 09, 2007. Female patient, 33 years of age, weighting 200.0 lb, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: rash pruritic. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, 39 years of age, weighting 209.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anger, asthenia, depressed mood, disturbance in attention, feeling jittery, headache, irritability, paranoia. BUPROPION dosage: 300 MG 1X DAY. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Mar 27, 2007. Female patient, 45 years of age, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: aggression, anger, heart rate increased. BUPROPION dosage: 150 MG QDAY PO. During the same period patient was treated with WELLBUTRIN, LEXAPRO, SUMATRIPTAN SUCCINATE. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 43 years of age, weighting 130.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, disease recurrence, gastrointestinal disorder, nausea. BUPROPION dosage: 1 300MG TABLET 1X DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 12, 2007. Female patient, weighting 130.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, emotional disorder, insomnia, irritability, social avoidant behaviour, suicidal ideation. BUPROPION dosage: 300 MG DAILY PO. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on Apr 11, 2007. Female patient, weighting 238.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, insomnia. BUPROPION dosage: 150 MG BID PO. Patient recovered.

Physician from UNITED STATES reported BUPROPION problem on Apr 13, 2007. Male patient, 36 years of age, weighting 175.0 lb, was diagnosed with affective disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, sleep disorder. BUPROPION dosage: 75 MG BID ORAL SUMMER - FALL 2006. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient, 23 years of age, weighting 135.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, asthenia, crying, decreased interest, depressed mood, feeling abnormal, heart rate increased, increased appetite. BUPROPION dosage: 300MG 1X/DAY PO. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on Apr 16, 2007. Female patient, 39 years of age, weighting 150.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: condition aggravated, depression. BUPROPION dosage: 300MG QD PO. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, weighting 165.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: diarrhoea. BUPROPION dosage: 300 MG ONCE DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 19, 2007. Female patient, weighting 145.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, disease recurrence. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Pharmacist from UNITED STATES on Apr 23, 2007. Female patient, 53 years of age, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: impaired healing, rash, urticaria. BUPROPION dosage: 150 MG BID PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 20, 2007. Female patient, 40 years of age, weighting 175.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, crying, depression, disturbance in attention, stress. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, 74 years of age, weighting 200.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: ventricular extrasystoles. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 20, 2007. Female patient, 32 years of age, weighting 160.0 lb, was diagnosed with binge eating, depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: binge eating, depression, disease recurrence, dry mouth, heart rate increased, insomnia, suicidal ideation. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on Apr 26, 2007. Female patient, 40 years of age, was diagnosed with anxiety, major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: affective disorder, apathy, dissociation, feeling abnormal, poor quality sleep, suicidal ideation. BUPROPION dosage: 150 MG PO QAM. During the same period patient was treated with LEXAPRO, KLONOPIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported BUPROPION problem on Apr 19, 2007. Female patient, 49 years of age, weighting 174.2 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: eye swelling, face oedema, headache, nasal congestion, palpitations. BUPROPION dosage: unknown. During the same period patient was treated with OXYTETRACYCLINE. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Female patient, 58 years of age, weighting 145.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, dizziness, hostility, hyperhidrosis, insomnia, tremor. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from ROMANIA reported BUPROPION problem on Apr 16, 2006. Female patient, 29 years of age, was diagnosed with ex-smoker and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: neutrophilia, oedema peripheral, polyarthritis, serum sickness, urticaria, vomiting, white blood cell count increased. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Female patient was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. BUPROPION dosage: 300 MG QDAY PO. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported BUPROPION problem on Apr 23, 2007. Female patient, 45 years of age, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: convulsion, pain, paralysis. BUPROPION dosage: unknown. During the same period patient was treated with PARACETAMOL. Patient was hospitalized and became disabled. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Male patient, weighting 237.9 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, mood altered. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on May 01, 2007. Female patient, 40 years of age, weighting 145.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: malaise. BUPROPION dosage: 300MG DAILY PO. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, weighting 160.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anger, anxiety, feeling abnormal, increased appetite, insomnia, panic attack, paranoia, sleep terror. BUPROPION dosage: 200 MG Q.D. AM PO. During the same period patient was treated with ADDERALL. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on May 03, 2007. Female patient, weighting 200.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: impaired driving ability, nausea. BUPROPION dosage: 150 MG 2/DAY MONTH. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on May 03, 2007. Female patient was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: adverse event, agitation. BUPROPION dosage: 300 MG XL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on May 03, 2007. Female patient, 42 years of age, weighting 130.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: agitation, depression, fatigue, feeling jittery, panic reaction, suicidal ideation. BUPROPION dosage: 300MG 1X/DAY PO. Patient recovered.

BUPROPION problem was reported by a Pharmacist from UNITED STATES on May 03, 2007. Female patient, weighting 130.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: dizziness, syncope. BUPROPION dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on Apr 25, 2007. Female patient was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: headache, suicidal ideation, visual disturbance. BUPROPION dosage: (300 MG QD ORAL). Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on May 07, 2007. Male patient, weighting 5.95 lb, was diagnosed with bipolar disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: neonatal aspiration. BUPROPION dosage: unknown. During the same period patient was treated with LAMOTRIGINE, XANAX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported BUPROPION problem on May 08, 2007. Female patient, 27 years of age, was diagnosed with major depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: abortion induced. BUPROPION dosage: 150MG PER DAY. During the same period patient was treated with LEXAPRO, KLONOPIN. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, weighting 370.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation. BUPROPION dosage: 300 MG DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on May 08, 2007. Male patient, 62 years of age, weighting 150.0 lb, was diagnosed with anxiety, depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, mood altered, nicotine dependence. BUPROPION dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

BUPROPION problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Male patient, weighting 215.0 lb, was diagnosed with bipolar disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety. BUPROPION dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported BUPROPION problem on May 09, 2007. Male patient, weighting 119.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: convulsion, dysarthria, dystonia, hallucination, incorrect dose administered, mental status changes, tachycardia. BUPROPION dosage: unknown. Patient was hospitalized. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Female patient, weighting 156.0 lb, was diagnosed with anxiety, depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, emotional disorder, fatigue. BUPROPION dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on May 14, 2007. Female patient, weighting 160.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression, fatigue, migraine, mood swings. BUPROPION dosage: unknown. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Male patient, 50 years of age, weighting 245.0 lb, was diagnosed with depression, pain, surgery and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: chest pain, crying, dyskinesia, hyperhidrosis, insomnia, nausea, nightmare, palpitations. BUPROPION dosage: 300 MG 1 DAY PO. Patient recovered.

Physician from UNITED STATES reported BUPROPION problem on May 18, 2007. Female patient, weighting 180.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression. BUPROPION dosage: 200 MG 1 QD PO. Patient recovered.

BUPROPION problem was reported by a Physician from UNITED STATES on May 21, 2007. Female patient was diagnosed with bipolar i disorder and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: asthenia, depressed mood, negativism, tearfulness. BUPROPION dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported BUPROPION problem on May 23, 2007. Male patient, 33 years of age, weighting 211.0 lb, was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: diarrhoea, feeling abnormal, lip swelling, oedema peripheral, pain, periorbital oedema, pyrexia. BUPROPION dosage: 150MG QD X 3D, THEN BID PO (DURATION: 21.5 D-AM DOSE ONLY). During the same period patient was treated with NICOTINE, NAPROXEN. Patient recovered.

BUPROPION problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Female patient, weighting 125.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: depression. BUPROPION dosage: 300 MG ONCE DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPROPION problem on May 23, 2007. Female patient, 49 years of age, weighting 118.0 lb, was diagnosed with depression and was treated with BUPROPION. After drug was administered, patient experienced the following problems/side effects: anxiety, depression. BUPROPION dosage: 300 MG ONCE PER DAY PO. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Showing 1-75 of 405 Next >

Ask Our Patient Community about BUPROPION

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
Quinapril